Panel discussion: developing careers within the bioanalytical field
Over the past 12 years, Bioanalysis Zone has supported and recognized early career researchers, as we believe it is important to support those who will establish themselves within the field and contribute integral research to the future of bioanalysis.
In this panel discussion, our experts met up whilst at the 15th EBF Open Symposium and discussed the challenges that early career researchers face and how they can overcome these obstacles to cement their reputation within the bioanalytical field. We also discussed how the recent pandemic has affected the career trajectory of those working within the bioanalytical field and what this might mean for the future of those looking to further their career progression and development.
What will you learn?
- How can early career researchers break into the industry
- The career challenges within the bioanalytical field and how can we resolve these challenges
- How the landscape has changed for those working within the field over the last 5 years
Who may this interest?
- Early career scientists
- Bioanalytical scientists
- Recent academic graduates
- Recruitment agencies
Speakers
Neil Spooner
Director and Founder
Spooner Bioanalytical Solutions Ltd (Hertford, UK)
Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling and patient centric sampling as well as analysis into workflows. He also works with organisations to develop technologies and introduce them to the market. Neil also assists organisations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire (Hertfordshire, UK), Editor in Chief of Bioanalysis Journal, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.
Tim Sangster
Executive Director of Bioanalytical Sciences
Celerion (NE, USA)
Tim is a well travelled experienced transformational executive who has led and expanded departments for the past 20 years. A well rounded bioanalytical specialist with strong regulatory experience supporting pharmaceutical development, with a range of other areas of research throughout his career, giving a wide range of experience and knowledge.
Fostering a culture of inclusiveness and support has led to his great success so far, the biggest achievements to date are measured by the many other great careers that he has had the great pleasure to give support to and learn from along the way. Coaching and mentoring has always been a key driver for him and also some of his proudest achievements.
Kurt Sales
Chief Scientific Officer
Agilex Biolabs (Adelaide, Australia)
Dr Kurt Sales has over 25 years of experience in a career spanning research and development, early drug discovery and regulated bioanalysis across preclinical and clinical drug development. At Agilex Biolabs, Kurt is Chief Scientific Officer, responsible for scientific integrity and strategic research and development.
Kurt has extensive expertise in preclinical and clinical assay development, cellular and molecular biology, molecular signaling, flow cytometry, cell-based models and biomarkers – notably in the areas of inflammation and immunology. Widely published, with 45 peer reviewed scientific papers in high-impact journals, book chapters and presentations at over 30 conferences. He also has extensive experience ensuring strict GLP compliance for bioanalytical assays and preclinical safety testing through PK/PD/Biomarker assays.
Kurt has a PhD in medical biochemistry, a Masters in biochemistry, a Bachelors of Science in medicine with Honours in pharmacology, and a Bachelor of Science in biochemistry and physiology. He has a Diploma in business organisation and management and a Post Graduate Certificate in management.
Daniel Schulz-Jander
Senior Director, Bioanalysis (Mass spectrometry)
QPS Netherlands (Groningen, Netherlands)
Daniel received his Dipl Chem from the University of Kassel (Kassel, Germany) in chemistry, his Doctor rerum naturalium from the Technische Universität München (Munich, Germany) in environmental chemistry, followed by a post-doctoral fellowship in pesticide metabolism at UC Berkeley (CA, USA). Since then, Daniel’s scientific passion has been in bioanalysis. Starting in biotech at Ligand and Arena Pharmaceuticals (CA, USA), he then moved to Medtronic (CA, USA) where he built a bioanalytical team specializing in drug in tissue analyses. Since February 2022, Daniel is currently the Senior Director of bioanalysis mass spectrometry at QPS Netherlands, where his team supports small and large molecule bioanalysis with LC-MS/MS as well as ICP/MS.
This webinar was recorded on Tuesday 28 February 2023.
In association with
